[EN] GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF<br/>[FR] DÉRIVÉ DE GLUCOPYRANOSYLE ET UTILISATION ASSOCIÉE
申请人:SUNSHINE LAKE PHARMA CO LTD
公开号:WO2019144864A1
公开(公告)日:2019-08-01
Provided are a glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
提供一种葡萄糖吡喃基衍生物作为一种钠依赖性葡萄糖转运蛋白抑制剂,特别是作为SGLT1抑制剂,其药用可接受盐或其立体异构体,以及其药物组合物,以及该化合物和药物组合物在制备用于治疗糖尿病和糖尿病相关疾病的药物中的用途。